Advanced Pancreatic Cancer
Showing 26 - 41 of 41
Advanced Pancreatic Cancer Trial in Beijing (Nab-paclitaxel and S-1)
Completed
- Advanced Pancreatic Cancer
- Nab-paclitaxel and S-1
-
Beijing, ChinaNational Cancer Center/Cancer Hospital, Chinese ACademy of Medic
Jan 29, 2021
Advanced Pancreatic Cancer Trial in Shanghai (cisplatin+Nab-paclitaxel+GEM, Nab-paclitaxel+GEM)
Not yet recruiting
- Advanced Pancreatic Cancer
-
Shanghai, Sahnghai, ChinaDepartment of Pancreatic and Hepatobiliary Surgery, Fudan Univer
Jan 10, 2021
Advanced Pancreatic Cancer Trial in Guangzhou (Activated CIK and CD3-MUC1 Bispecific Antibody in Treating Pancreatic Cancer,
Withdrawn
- Advanced Pancreatic Cancer
- Activated CIK and CD3-MUC1 Bispecific Antibody in Treating Pancreatic Cancer
- cryotherapy
-
Guangzhou, Guangdong, ChinaInstitutional Review Board of Guangzhou Fuda Cancer Hospital
Oct 13, 2020
Advanced Pancreatic Cancer Trial in New York (ADI-PEG 20)
Completed
- Advanced Pancreatic Cancer
- ADI-PEG 20
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Sep 30, 2020
Advanced Pancreatic Cancer Trial in Shanghai, Hangzhou (Fluzoparib, Fluzoparib , mFOLFIRINOX)
Recruiting
- Advanced Pancreatic Cancer
- Fluzoparib
- +2 more
-
Shanghai, Shanghai, China
- +1 more
Aug 9, 2020
Advanced Pancreatic Cancer Trial in Honolulu (Gemcitabine, Nab-paclitaxel, ALT-803)
Completed
- Advanced Pancreatic Cancer
- Gemcitabine
- +2 more
-
Honolulu, HawaiiUniversity of Hawaii Cancer Center
Jan 24, 2020
Advanced Pancreatic Cancer Trial in Beijing (PEG-rhG-CSF)
Unknown status
- Advanced Pancreatic Cancer
-
Beijing, ChinaChinese PLA General Hospital First medical center
Jan 20, 2020
Advanced Pancreatic Cancer Trial in Shanghai (Paclitaxel liposome, S-1)
Not yet recruiting
- Advanced Pancreatic Cancer
- Paclitaxel liposome
- S-1
-
Shanghai, ChinaDepartment of Pancreatic and Hepatobiliary Surgery, Fudan Univer
Jan 1, 2020
Advanced Pancreatic Cancer Trial in Beijing (nanoparticle albumin-bound paclitaxel, S-1)
Unknown status
- Advanced Pancreatic Cancer
- nanoparticle albumin-bound paclitaxel
- S-1
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Dec 21, 2016
Advanced Pancreatic Cancer Trial in Spain (Nab-paclitaxel 150 mg/m2 + Gemcitabine 1000 weeks 1,3/4, Nab-paclitaxel 100 mg/m2 +
Completed
- Advanced Pancreatic Cancer
- Nab-paclitaxel 150 mg/m2 + Gemcitabine 1000 weeks 1,3/4
- +3 more
-
Santiago de Compostela, A Cosuña, Spain
- +14 more
Jul 5, 2016
Advanced Pancreatic Cancer Trial in Pittsburgh (Embedded Supportive Care)
Completed
- Advanced Pancreatic Cancer
- Embedded Supportive Care
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh Cancer Institute (UPCI), Hillman Cancer
May 10, 2016
Advanced Pancreatic Cancer Trial in Beijing (nanoparticle albumin-bound paclitaxel, gemcitabine)
Unknown status
- Advanced Pancreatic Cancer
- nanoparticle albumin-bound paclitaxel
- gemcitabine
-
Beijing, Beijing, ChinaChinese PLA General Hospital
May 15, 2014
Advanced Pancreatic Cancer Trial in Sutton (Gemcitabine, Oxaliplatin, Imatinib)
Completed
- Advanced Pancreatic Cancer
- Gemcitabine
- +2 more
-
Sutton, Surrey, United KingdomRoyal Marsden NHS Foundation Trust
Sep 21, 2012